Skip to main content

OS Therapies Inc

OSTX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001795091

No open-market purchases or sales by OS Therapies Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $5.50M in total; no superinvestor holds it.

Superinvestors holding OSTX, Q2 2026

See all superinvestors

No superinvestor reported holding OSTX in Q2 2026.